VP16-213 and podophyllotoxin
- 1 April 1982
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (2-3) , 103-111
- https://doi.org/10.1007/bf00254530
Abstract
VP16-213, a semi-synthetic derivative of podophyllotoxin, is an effective antitumor agent in the treatment of a variety of leukemias and solid tumors. A comparison of the mechanism of action of VP16-213 and podophyllotoxin has revealed that although both drugs inhibit the uptake of nucleosides into HeLa cells, they exhibit other biological properties which are quite distinct. Podophyllotoxin is a potent inhibitor of microtubule assembly in vitro, while VP16-213 has no effect in this system. VP16-213 induces single stranded breaks in HeLa cell DNA, an effect which may be related to its antitumor activity. In contrast to VP16-213-treated cells, podophyllotoxin-treated cells maintain DNA integrity. Structure-activity relationship studies have identified some of the chemical sites of VP16-213 and podophyllotoxin responsible for each of their biological properties. These studies illustrate that chemical modification of podophyllotoxin can generate derivatives which possess new and unique biological properties.Keywords
This publication has 43 references indexed in Scilit:
- Kinetic and steady-state analysis of microtubules in the presence of colchicineBiochemistry, 1981
- Phorbol myristate acetate stimulates microtubule and 10-nm filament extension and lysosome redistribution in mouse macrophages.The Journal of cell biology, 1980
- A quantitative microdensitometric and autoradiographic study of the effect of 4?-demethyl-epipodophyllotoxin-?-D-thenylidene glucoside (VM-26) on the cell cycle of cultured fibroblastsJournal of Molecular Histology, 1979
- Thymidine transport in cultured mammalian cells. Kinetic analysis, temperature dependence and specificity of the transport systemBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Chemotherapy of small cell carcinoma of the lung with V. P. 16–213Cancer, 1978
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesPublished by Elsevier ,1975
- Transport of nucleosides, nucleic acid bases, choline and glucose by animal cells in cultureBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1974
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973
- Inhibition of NADH-linked respiration with the anti-cancer agent 4′-demethyl-epipodophyllotoxin thenylidene glucoside (VM-26)Published by Elsevier ,1972
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionPublished by Elsevier ,1970